1 Study Coverage
1.1 Direct-to-consumer Disease Risk and Health Genetic Test Product Introduction
1.2 Market by Type
1.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Celiac Disease
1.2.3 Parkinson Disease
1.2.4 Alzheimer Disease
1.2.5 Other
1.3 Market by Application
1.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
2 Global Direct-to-consumer Disease Risk and Health Genetic Test Production
2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Production Capacity (2017-2028)
2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Production by Region: 2017 VS 2021 VS 2028
2.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Production by Region
2.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Historic Production by Region (2017-2022)
2.3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume & Value Estimates and Forecasts
3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Estimates and Forecasts 2017-2028
3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Estimates and Forecasts 2017-2028
3.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Region
3.4.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Region (2017-2022)
3.4.2 Global Sales Direct-to-consumer Disease Risk and Health Genetic Test by Region (2023-2028)
3.5 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region
3.5.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region (2017-2022)
3.5.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Production Capacity by Manufacturers
4.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Manufacturers
4.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Manufacturers (2017-2022)
4.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Direct-to-consumer Disease Risk and Health Genetic Test in 2021
4.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Manufacturers
4.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Manufacturers (2017-2022)
4.3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Direct-to-consumer Disease Risk and Health Genetic Test Revenue in 2021
4.4 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type
5.1.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Historical Sales by Type (2017-2022)
5.1.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecasted Sales by Type (2023-2028)
5.1.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Type (2017-2028)
5.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type
5.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Historical Revenue by Type (2017-2022)
5.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecasted Revenue by Type (2023-2028)
5.2.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Type (2017-2028)
5.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Type
5.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Type (2017-2022)
5.3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application
6.1.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Historical Sales by Application (2017-2022)
6.1.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecasted Sales by Application (2023-2028)
6.1.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Application (2017-2028)
6.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application
6.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Historical Revenue by Application (2017-2022)
6.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Forecasted Revenue by Application (2023-2028)
6.2.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Application (2017-2028)
6.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Application
6.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Application (2017-2022)
6.3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Price Forecast by Application (2023-2028)
7 North America
7.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type
7.1.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2028)
7.1.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2028)
7.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application
7.2.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2028)
7.2.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2028)
7.3 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country
7.3.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2017-2028)
7.3.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type
8.1.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2028)
8.1.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2028)
8.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application
8.2.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2028)
8.2.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2028)
8.3 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country
8.3.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2017-2028)
8.3.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type
9.1.1 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2028)
9.1.2 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2028)
9.2 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application
9.2.1 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2028)
9.2.2 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2028)
9.3 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Region
9.3.1 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Region (2017-2028)
9.3.2 Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type
10.1.1 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2028)
10.1.2 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2028)
10.2 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application
10.2.1 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2028)
10.2.2 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2028)
10.3 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country
10.3.1 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2017-2028)
10.3.2 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type
11.1.1 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2028)
11.1.2 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2028)
11.2 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application
11.2.1 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2028)
11.2.2 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2028)
11.3 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country
11.3.1 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2017-2028)
11.3.2 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 23andMe
12.1.1 23andMe Corporation Information
12.1.2 23andMe Overview
12.1.3 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 23andMe Recent Developments
12.2 MyHeritage
12.2.1 MyHeritage Corporation Information
12.2.2 MyHeritage Overview
12.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 MyHeritage Recent Developments
12.3 LabCorp
12.3.1 LabCorp Corporation Information
12.3.2 LabCorp Overview
12.3.3 LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 LabCorp Recent Developments
12.4 Myriad Genetics
12.4.1 Myriad Genetics Corporation Information
12.4.2 Myriad Genetics Overview
12.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Myriad Genetics Recent Developments
12.5 Ancestry.com
12.5.1 Ancestry.com Corporation Information
12.5.2 Ancestry.com Overview
12.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Ancestry.com Recent Developments
12.6 Quest Diagnostics
12.6.1 Quest Diagnostics Corporation Information
12.6.2 Quest Diagnostics Overview
12.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Quest Diagnostics Recent Developments
12.7 Gene By Gene
12.7.1 Gene By Gene Corporation Information
12.7.2 Gene By Gene Overview
12.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Gene By Gene Recent Developments
12.8 DNA Diagnostics Center
12.8.1 DNA Diagnostics Center Corporation Information
12.8.2 DNA Diagnostics Center Overview
12.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 DNA Diagnostics Center Recent Developments
12.9 Invitae
12.9.1 Invitae Corporation Information
12.9.2 Invitae Overview
12.9.3 Invitae Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Invitae Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Invitae Recent Developments
12.10 IntelliGenetics
12.10.1 IntelliGenetics Corporation Information
12.10.2 IntelliGenetics Overview
12.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 IntelliGenetics Recent Developments
12.11 Ambry Genetics
12.11.1 Ambry Genetics Corporation Information
12.11.2 Ambry Genetics Overview
12.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Ambry Genetics Recent Developments
12.12 Living DNA
12.12.1 Living DNA Corporation Information
12.12.2 Living DNA Overview
12.12.3 Living DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Living DNA Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Living DNA Recent Developments
12.13 EasyDNA
12.13.1 EasyDNA Corporation Information
12.13.2 EasyDNA Overview
12.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 EasyDNA Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 EasyDNA Recent Developments
12.14 Pathway Genomics
12.14.1 Pathway Genomics Corporation Information
12.14.2 Pathway Genomics Overview
12.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Pathway Genomics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Pathway Genomics Recent Developments
12.15 Centrillion Technology
12.15.1 Centrillion Technology Corporation Information
12.15.2 Centrillion Technology Overview
12.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Centrillion Technology Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Centrillion Technology Recent Developments
12.16 Xcode
12.16.1 Xcode Corporation Information
12.16.2 Xcode Overview
12.16.3 Xcode Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Xcode Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Xcode Recent Developments
12.17 Color Genomics
12.17.1 Color Genomics Corporation Information
12.17.2 Color Genomics Overview
12.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Color Genomics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Color Genomics Recent Developments
12.18 Anglia DNA Services
12.18.1 Anglia DNA Services Corporation Information
12.18.2 Anglia DNA Services Overview
12.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Anglia DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Anglia DNA Services Recent Developments
12.19 African Ancestry
12.19.1 African Ancestry Corporation Information
12.19.2 African Ancestry Overview
12.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 African Ancestry Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 African Ancestry Recent Developments
12.20 Canadian DNA Services
12.20.1 Canadian DNA Services Corporation Information
12.20.2 Canadian DNA Services Overview
12.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 Canadian DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Canadian DNA Services Recent Developments
12.21 DNA Family Check
12.21.1 DNA Family Check Corporation Information
12.21.2 DNA Family Check Overview
12.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.21.4 DNA Family Check Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.21.5 DNA Family Check Recent Developments
12.22 Alpha Biolaboratories
12.22.1 Alpha Biolaboratories Corporation Information
12.22.2 Alpha Biolaboratories Overview
12.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.22.4 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.22.5 Alpha Biolaboratories Recent Developments
12.23 Test Me DNA
12.23.1 Test Me DNA Corporation Information
12.23.2 Test Me DNA Overview
12.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.23.4 Test Me DNA Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.23.5 Test Me DNA Recent Developments
12.24 23 Mofang
12.24.1 23 Mofang Corporation Information
12.24.2 23 Mofang Overview
12.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.24.4 23 Mofang Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.24.5 23 Mofang Recent Developments
12.25 Genetic Health
12.25.1 Genetic Health Corporation Information
12.25.2 Genetic Health Overview
12.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.25.4 Genetic Health Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.25.5 Genetic Health Recent Developments
12.26 DNA Services of America
12.26.1 DNA Services of America Corporation Information
12.26.2 DNA Services of America Overview
12.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.26.4 DNA Services of America Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.26.5 DNA Services of America Recent Developments
12.27 Shuwen Health Sciences
12.27.1 Shuwen Health Sciences Corporation Information
12.27.2 Shuwen Health Sciences Overview
12.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.27.4 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.27.5 Shuwen Health Sciences Recent Developments
12.28 Mapmygenome
12.28.1 Mapmygenome Corporation Information
12.28.2 Mapmygenome Overview
12.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.28.4 Mapmygenome Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.28.5 Mapmygenome Recent Developments
12.29 Full Genomes
12.29.1 Full Genomes Corporation Information
12.29.2 Full Genomes Overview
12.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Genetic Test Sales, Price, Revenue and Gross Margin (2017-2022)
12.29.4 Full Genomes Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
12.29.5 Full Genomes Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Direct-to-consumer Disease Risk and Health Genetic Test Industry Chain Analysis
13.2 Direct-to-consumer Disease Risk and Health Genetic Test Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Direct-to-consumer Disease Risk and Health Genetic Test Production Mode & Process
13.4 Direct-to-consumer Disease Risk and Health Genetic Test Sales and Marketing
13.4.1 Direct-to-consumer Disease Risk and Health Genetic Test Sales Channels
13.4.2 Direct-to-consumer Disease Risk and Health Genetic Test Distributors
13.5 Direct-to-consumer Disease Risk and Health Genetic Test Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Direct-to-consumer Disease Risk and Health Genetic Test Industry Trends
14.2 Direct-to-consumer Disease Risk and Health Genetic Test Market Drivers
14.3 Direct-to-consumer Disease Risk and Health Genetic Test Market Challenges
14.4 Direct-to-consumer Disease Risk and Health Genetic Test Market Restraints
15 Key Finding in The Global Direct-to-consumer Disease Risk and Health Genetic Test Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Celiac Disease
Table 3. Major Manufacturers of Parkinson Disease
Table 4. Major Manufacturers of Alzheimer Disease
Table 5. Major Manufacturers of Other
Table 6. Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 7. Global Direct-to-consumer Disease Risk and Health Genetic Test Production by Region: 2017 VS 2021 VS 2028 (K Units)
Table 8. Global Direct-to-consumer Disease Risk and Health Genetic Test Production by Region (2017-2022) & (K Units)
Table 9. Global Direct-to-consumer Disease Risk and Health Genetic Test Production Market Share by Region (2017-2022)
Table 10. Global Direct-to-consumer Disease Risk and Health Genetic Test Production by Region (2023-2028) & (K Units)
Table 11. Global Direct-to-consumer Disease Risk and Health Genetic Test Production Market Share by Region (2023-2028)
Table 12. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 13. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Region (2017-2022) & (K Units)
Table 14. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Region (2017-2022)
Table 15. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Region (2023-2028) & (K Units)
Table 16. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Region (2023-2028)
Table 17. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Region (2017-2022)
Table 19. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region (2023-2028) & (US$ Million)
Table 20. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Market Share by Region (2023-2028)
Table 21. Global Direct-to-consumer Disease Risk and Health Genetic Test Production Capacity by Manufacturers (2017-2022) & (K Units)
Table 22. Global Direct-to-consumer Disease Risk and Health Genetic Test Capacity Market Share by Manufacturers (2017-2022)
Table 23. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Manufacturers (2017-2022) & (K Units)
Table 24. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share by Manufacturers (2017-2022)
Table 25. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 26. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Share by Manufacturers (2017-2022)
Table 27. Direct-to-consumer Disease Risk and Health Genetic Test Price by Manufacturers 2017-2022 (USD/Unit)
Table 28. Global Direct-to-consumer Disease Risk and Health Genetic Test Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Direct-to-consumer Disease Risk and Health Genetic Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Genetic Test as of 2021)
Table 30. Direct-to-consumer Disease Risk and Health Genetic Test Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Direct-to-consumer Disease Risk and Health Genetic Test Product Offered
Table 32. Date of Manufacturers Enter into Direct-to-consumer Disease Risk and Health Genetic Test Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2022) & (K Units)
Table 35. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2023-2028) & (K Units)
Table 36. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Share by Type (2017-2022)
Table 37. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Share by Type (2023-2028)
Table 38. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2022) & (US$ Million)
Table 39. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2023-2028) & (US$ Million)
Table 40. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Share by Type (2017-2022)
Table 41. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Share by Type (2023-2028)
Table 42. Direct-to-consumer Disease Risk and Health Genetic Test Price by Type (2017-2022) & (USD/Unit)
Table 43. Global Direct-to-consumer Disease Risk and Health Genetic Test Price Forecast by Type (2023-2028) & (USD/Unit)
Table 44. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2022) & (K Units)
Table 45. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2023-2028) & (K Units)
Table 46. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Share by Application (2017-2022)
Table 47. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Share by Application (2023-2028)
Table 48. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2022) & (US$ Million)
Table 49. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2023-2028) & (US$ Million)
Table 50. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Share by Application (2017-2022)
Table 51. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Share by Application (2023-2028)
Table 52. Direct-to-consumer Disease Risk and Health Genetic Test Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Direct-to-consumer Disease Risk and Health Genetic Test Price Forecast by Application (2023-2028) & (USD/Unit)
Table 54. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2022) & (K Units)
Table 55. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2023-2028) & (K Units)
Table 56. North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2022) & (K Units)
Table 59. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2023-2028) & (K Units)
Table 60. North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2017-2022) & (K Units)
Table 63. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2023-2028) & (K Units)
Table 64. North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2022) & (K Units)
Table 67. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2023-2028) & (K Units)
Table 68. Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2022) & (US$ Million)
Table 69. Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2023-2028) & (US$ Million)
Table 70. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2022) & (K Units)
Table 71. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2023-2028) & (K Units)
Table 72. Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2022) & (US$ Million)
Table 73. Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2023-2028) & (US$ Million)
Table 74. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2017-2022) & (K Units)
Table 75. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2023-2028) & (K Units)
Table 76. Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2017-2022) & (US$ Million)
Table 77. Europe Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2023-2028) & (US$ Million)
Table 78. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2022) & (K Units)
Table 79. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2023-2028) & (K Units)
Table 80. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2022) & (US$ Million)
Table 81. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2023-2028) & (US$ Million)
Table 82. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2022) & (K Units)
Table 83. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2023-2028) & (K Units)
Table 84. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2022) & (US$ Million)
Table 85. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2023-2028) & (US$ Million)
Table 86. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Region (2017-2022) & (K Units)
Table 87. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales by Region (2023-2028) & (K Units)
Table 88. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region (2017-2022) & (US$ Million)
Table 89. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Region (2023-2028) & (US$ Million)
Table 90. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2022) & (K Units)
Table 91. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2023-2028) & (K Units)
Table 92. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2022) & (US$ Million)
Table 93. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2023-2028) & (US$ Million)
Table 94. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2022) & (K Units)
Table 95. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2023-2028) & (K Units)
Table 96. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2022) & (US$ Million)
Table 97. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2023-2028) & (US$ Million)
Table 98. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2017-2022) & (K Units)
Table 99. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2023-2028) & (K Units)
Table 100. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2017-2022) & (US$ Million)
Table 101. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2022) & (K Units)
Table 103. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2023-2028) & (K Units)
Table 104. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Type (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2022) & (K Units)
Table 107. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2023-2028) & (K Units)
Table 108. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Application (2023-2028) & (US$ Million)
Table 110. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2017-2022) & (K Units)
Table 111. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales by Country (2023-2028) & (K Units)
Table 112. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2017-2022) & (US$ Million)
Table 113. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Country (2023-2028) & (US$ Million)
Table 114. 23andMe Corporation Information
Table 115. 23andMe Description and Major Businesses
Table 116. 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. 23andMe Recent Development
Table 119. MyHeritage Corporation Information
Table 120. MyHeritage Description and Major Businesses
Table 121. MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. MyHeritage Recent Development
Table 124. LabCorp Corporation Information
Table 125. LabCorp Description and Major Businesses
Table 126. LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. LabCorp Recent Development
Table 129. Myriad Genetics Corporation Information
Table 130. Myriad Genetics Description and Major Businesses
Table 131. Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Myriad Genetics Recent Development
Table 134. Ancestry.com Corporation Information
Table 135. Ancestry.com Description and Major Businesses
Table 136. Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Ancestry.com Recent Development
Table 139. Quest Diagnostics Corporation Information
Table 140. Quest Diagnostics Description and Major Businesses
Table 141. Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Quest Diagnostics Recent Development
Table 144. Gene By Gene Corporation Information
Table 145. Gene By Gene Description and Major Businesses
Table 146. Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Gene By Gene Recent Development
Table 149. DNA Diagnostics Center Corporation Information
Table 150. DNA Diagnostics Center Description and Major Businesses
Table 151. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. DNA Diagnostics Center Recent Development
Table 154. Invitae Corporation Information
Table 155. Invitae Description and Major Businesses
Table 156. Invitae Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. Invitae Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Invitae Recent Development
Table 159. IntelliGenetics Corporation Information
Table 160. IntelliGenetics Description and Major Businesses
Table 161. IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 162. IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. IntelliGenetics Recent Development
Table 164. Ambry Genetics Corporation Information
Table 165. Ambry Genetics Description and Major Businesses
Table 166. Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 167. Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Ambry Genetics Recent Development
Table 169. Living DNA Corporation Information
Table 170. Living DNA Description and Major Businesses
Table 171. Living DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 172. Living DNA Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Living DNA Recent Development
Table 174. EasyDNA Corporation Information
Table 175. EasyDNA Description and Major Businesses
Table 176. EasyDNA Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 177. EasyDNA Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. EasyDNA Recent Development
Table 179. Pathway Genomics Corporation Information
Table 180. Pathway Genomics Description and Major Businesses
Table 181. Pathway Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 182. Pathway Genomics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Pathway Genomics Recent Development
Table 184. Centrillion Technology Corporation Information
Table 185. Centrillion Technology Description and Major Businesses
Table 186. Centrillion Technology Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 187. Centrillion Technology Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Centrillion Technology Recent Development
Table 189. Xcode Corporation Information
Table 190. Xcode Description and Major Businesses
Table 191. Xcode Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 192. Xcode Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Xcode Recent Development
Table 194. Color Genomics Corporation Information
Table 195. Color Genomics Description and Major Businesses
Table 196. Color Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 197. Color Genomics Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Color Genomics Recent Development
Table 199. Anglia DNA Services Corporation Information
Table 200. Anglia DNA Services Description and Major Businesses
Table 201. Anglia DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 202. Anglia DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Anglia DNA Services Recent Development
Table 204. African Ancestry Corporation Information
Table 205. African Ancestry Description and Major Businesses
Table 206. African Ancestry Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 207. African Ancestry Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 208. African Ancestry Recent Development
Table 209. Canadian DNA Services Corporation Information
Table 210. Canadian DNA Services Description and Major Businesses
Table 211. Canadian DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 212. Canadian DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 213. Canadian DNA Services Recent Development
Table 214. DNA Family Check Corporation Information
Table 215. DNA Family Check Description and Major Businesses
Table 216. DNA Family Check Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 217. DNA Family Check Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 218. DNA Family Check Recent Development
Table 219. Alpha Biolaboratories Corporation Information
Table 220. Alpha Biolaboratories Description and Major Businesses
Table 221. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 222. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 223. Alpha Biolaboratories Recent Development
Table 224. Test Me DNA Corporation Information
Table 225. Test Me DNA Description and Major Businesses
Table 226. Test Me DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 227. Test Me DNA Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 228. Test Me DNA Recent Development
Table 229. 23 Mofang Corporation Information
Table 230. 23 Mofang Description and Major Businesses
Table 231. 23 Mofang Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 232. 23 Mofang Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 233. 23 Mofang Recent Development
Table 234. Genetic Health Corporation Information
Table 235. Genetic Health Description and Major Businesses
Table 236. Genetic Health Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 237. Genetic Health Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 238. Genetic Health Recent Development
Table 239. DNA Services of America Corporation Information
Table 240. DNA Services of America Description and Major Businesses
Table 241. DNA Services of America Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 242. DNA Services of America Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 243. DNA Services of America Recent Development
Table 244. Shuwen Health Sciences Corporation Information
Table 245. Shuwen Health Sciences Description and Major Businesses
Table 246. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 247. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 248. Shuwen Health Sciences Recent Development
Table 249. Mapmygenome Corporation Information
Table 250. Mapmygenome Description and Major Businesses
Table 251. Mapmygenome Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 252. Mapmygenome Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 253. Mapmygenome Recent Development
Table 254. Full Genomes Corporation Information
Table 255. Full Genomes Description and Major Businesses
Table 256. Full Genomes Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 257. Full Genomes Direct-to-consumer Disease Risk and Health Genetic Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 258. Full Genomes Recent Development
Table 259. Key Raw Materials Lists
Table 260. Raw Materials Key Suppliers Lists
Table 261. Direct-to-consumer Disease Risk and Health Genetic Test Distributors List
Table 262. Direct-to-consumer Disease Risk and Health Genetic Test Customers List
Table 263. Direct-to-consumer Disease Risk and Health Genetic Test Market Trends
Table 264. Direct-to-consumer Disease Risk and Health Genetic Test Market Drivers
Table 265. Direct-to-consumer Disease Risk and Health Genetic Test Market Challenges
Table 266. Direct-to-consumer Disease Risk and Health Genetic Test Market Restraints
Table 267. Research Programs/Design for This Report
Table 268. Key Data Information from Secondary Sources
Table 269. Key Data Information from Primary Sources
List of Figures
Figure 1. Direct-to-consumer Disease Risk and Health Genetic Test Product Picture
Figure 2. Global Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Type in 2021 & 2028
Figure 3. Celiac Disease Product Picture
Figure 4. Parkinson Disease Product Picture
Figure 5. Alzheimer Disease Product Picture
Figure 6. Other Product Picture
Figure 7. Global Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Application in 2021 & 2028
Figure 8. Online
Figure 9. Offline
Figure 10. Direct-to-consumer Disease Risk and Health Genetic Test Report Years Considered
Figure 11. Global Direct-to-consumer Disease Risk and Health Genetic Test Capacity, Production and Utilization (2017-2028) & (K Units)
Figure 12. Global Direct-to-consumer Disease Risk and Health Genetic Test Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Direct-to-consumer Disease Risk and Health Genetic Test Production Market Share by Region (2017-2022)
Figure 14. Global Direct-to-consumer Disease Risk and Health Genetic Test Production Market Share by Region (2023-2028)
Figure 15. Direct-to-consumer Disease Risk and Health Genetic Test Production Growth Rate in North America (2017-2028) & (K Units)
Figure 16. Direct-to-consumer Disease Risk and Health Genetic Test Production Growth Rate in Europe (2017-2028) & (K Units)
Figure 17. Direct-to-consumer Disease Risk and Health Genetic Test Production Growth Rate in China (2017-2028) & (K Units)
Figure 18. Direct-to-consumer Disease Risk and Health Genetic Test Production Growth Rate in Japan (2017-2028) & (K Units)
Figure 19. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales 2017-2028 (K Units)
Figure 20. Global Direct-to-consumer Disease Risk and
